Morgan RD, Banerjee S, Hall M, Clamp AR, et al. Pazopanib and Fosbretabulin in recurrent ovarian cancer (PAZOFOS): A
multi-centre, phase 1b and open-label, randomised phase 2 trial. Gynecol Oncol 2020 Jan 10. pii: S0090-8258(20)30005.
PMID: 31932108